Outset Medical Inc (OM) - Total Liabilities
Based on the latest financial reports, Outset Medical Inc (OM) has total liabilities worth $137.54 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore OM operating cash flow to assess how effectively this company generates cash.
Outset Medical Inc - Total Liabilities Trend (2018–2025)
This chart illustrates how Outset Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Check Outset Medical Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Outset Medical Inc Competitors by Total Liabilities
The table below lists competitors of Outset Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Premium Snacks Nordic AB
ST:SNX
|
Sweden | Skr132.05 Million |
|
Global Fashion Group SA
XETRA:GFG
|
Germany | €353.40 Million |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr230.13 Million |
|
Seafco Public Company Limited
BK:SEAFCO
|
Thailand | ฿925.07 Million |
|
Careium AB
ST:CARE
|
Sweden | Skr407.40 Million |
|
Thorney Opportunities Ltd
AU:TOP
|
Australia | AU$21.80 Million |
|
IZEA Inc
NASDAQ:IZEA
|
USA | $8.00 Million |
|
S Chand And Company Limited
NSE:SCHAND
|
India | Rs3.16 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Outset Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Outset Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Outset Medical Inc (2018–2025)
The table below shows the annual total liabilities of Outset Medical Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $137.54 Million | -44.76% |
| 2024-12-31 | $248.98 Million | +30.41% |
| 2023-12-31 | $190.91 Million | +23.87% |
| 2022-12-31 | $154.12 Million | +72.43% |
| 2021-12-31 | $89.38 Million | +18.83% |
| 2020-12-31 | $75.22 Million | -83.67% |
| 2019-12-31 | $460.55 Million | +4.89% |
| 2018-12-31 | $439.08 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, … Read more